Bank Of America Corp Aurinia Pharmaceuticals Inc. Transaction History

Bank Of America Corp

$1.17 Trillion
Q4 2024

A detailed history of Bank Of America Corp transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Bank Of America Corp holds 63,975 shares of AUPH stock, worth $514,998. This represents 0.0% of its overall portfolio holdings.

Number of Shares

63,975

Previous 174,690 63.38%

Holding current value

$514,998

Previous $1.28 Million 55.16%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$6.75 - $10.44 $747,326 - $1.16 Million	-110,715 Reduced 63.38%	63,975 $574,000
Q3 2024 Nov 14, 2024	BUY	$5.32 - $7.33 $118,721 - $163,576	22,316 Added 14.65%	174,690 $1.28 Million
Q2 2024 Aug 14, 2024	BUY	$4.81 - $5.78 $173,010 - $207,900	35,969 Added 30.9%	152,374 $870,000
Q1 2024 May 15, 2024	BUY	$4.93 - $9.31 $231,665 - $437,486	46,991 Added 67.7%	116,405 $583,000
Q4 2023 Feb 14, 2024	BUY	$7.13 - $9.49 $43,236 - $57,547	6,064 Added 9.57%	69,414 $624,000
Q2 2023 Aug 14, 2023	SELL	$8.96 - $11.69 $357,996 - $467,073	-39,955 Reduced 38.68%	63,350 $613,000
Q1 2023 May 12, 2023	SELL	$5.94 - $11.27 $1.81 Million - $3.44 Million	-305,421 Reduced 74.73%	103,305 $1.13 Million
Q4 2022 Feb 10, 2023	BUY	$4.11 - $8.14 $614,481 - $1.22 Million	149,509 Added 57.68%	408,726 $1.77 Million
Q3 2022 Nov 14, 2022	BUY	$6.66 - $12.39 $879,672 - $1.64 Million	132,083 Added 103.89%	259,217 $1.95 Million
Q2 2022 Aug 12, 2022	BUY	$8.95 - $12.8 $645,849 - $923,673	72,162 Added 131.27%	127,134 $1.28 Million
Q1 2022 May 16, 2022	SELL	$10.05 - $22.48 $72,661 - $162,530	-7,230 Reduced 11.62%	54,972 $680,000
Q4 2021 Feb 08, 2022	BUY	$17.78 - $33.08 $324,609 - $603,941	18,257 Added 41.55%	62,202 $1.42 Million
Q3 2021 Nov 15, 2021	SELL	$10.93 - $23.55 $148,833 - $320,680	-13,617 Reduced 23.66%	43,945 $973,000
Q2 2021 Sep 13, 2021	BUY	$10.0 - $14.52 $575,620 - $835,800	57,562 New	57,562 $746,000

Others Institutions Holding AUPH

# of Institutions

227

Shares Held

58.9M

Call Options Held

949K

Put Options Held

1.51M

View Full List

About Aurinia Pharmaceuticals Inc.

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.14B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

More about AUPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Aurinia Pharmaceuticals Inc. Transaction History